BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11298597)

  • 1. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation.
    Petersdorf EW; Gooley T; Malkki M; Anasetti C; Martin P; Woolfrey A; Smith A; Mickelson E; Hansen JA
    Br J Haematol; 2001 Mar; 112(4):988-94. PubMed ID: 11298597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation.
    Varney MD; Lester S; McCluskey J; Gao X; Tait BD
    Hum Immunol; 1999 Jun; 60(6):532-8. PubMed ID: 10408803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High HLA-DP Expression and Graft-versus-Host Disease.
    Petersdorf EW; Malkki M; O'hUigin C; Carrington M; Gooley T; Haagenson MD; Horowitz MM; Spellman SR; Wang T; Stevenson P
    N Engl J Med; 2015 Aug; 373(7):599-609. PubMed ID: 26267621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
    Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
    Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
    Pidala J; Lee SJ; Ahn KW; Spellman S; Wang HL; Aljurf M; Askar M; Dehn J; Fernandez Viña M; Gratwohl A; Gupta V; Hanna R; Horowitz MM; Hurley CK; Inamoto Y; Kassim AA; Nishihori T; Mueller C; Oudshoorn M; Petersdorf EW; Prasad V; Robinson J; Saber W; Schultz KR; Shaw B; Storek J; Wood WA; Woolfrey AE; Anasetti C
    Blood; 2014 Oct; 124(16):2596-606. PubMed ID: 25161269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.
    Shaw BE; Gooley TA; Malkki M; Madrigal JA; Begovich AB; Horowitz MM; Gratwohl A; Ringdén O; Marsh SG; Petersdorf EW
    Blood; 2007 Dec; 110(13):4560-6. PubMed ID: 17726164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
    Petersdorf EW; Bengtsson M; De Santis D; Dubois V; Fleischhauer K; Gooley T; Horowitz M; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P; Carrington M; ;
    J Clin Oncol; 2020 Aug; 38(24):2712-2718. PubMed ID: 32479188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
    Petersdorf EW; Smith AG; Mickelson EM; Longton GM; Anasetti C; Choo SY; Martin PJ; Hansen JA
    Blood; 1993 Apr; 81(7):1923-32. PubMed ID: 8461476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
    Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
    Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation.
    Shaw BE; Potter MN; Mayor NP; Pay AL; Smith C; Goldman JM; Prentice HG; Marsh SG; Madrigal JA
    Bone Marrow Transplant; 2003 Jun; 31(11):1001-8. PubMed ID: 12774051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
    Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
    Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
    Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
    Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
    Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
    Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DPB1 mismatch and acute graft-versus host disease in HLA-identical sibling donors.
    Mosaad YM; Kamel H
    Egypt J Immunol; 2005; 12(2):21-8. PubMed ID: 17977207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
    Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.
    Yabe T; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Morishima S; Satake M; Takanashi M; Nakajima K; Morishima Y;
    Leukemia; 2018 Jan; 32(1):168-175. PubMed ID: 28652579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between HLA-DPB1 matching and 1-year rejection-free graft survival in high-risk corneal transplantation.
    Munkhbat B; Hagihara M; Sato T; Tsuchida F; Sato K; Shimazaki J; Tsubota K; Tsuji K
    Transplantation; 1997 Apr; 63(7):1011-6. PubMed ID: 9112356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.
    Burek Kamenaric M; Maskalan M; Grubic Z; Mikulic M; Serventi Seiwerth R; Durakovic N; Vrhovac R; Stingl Jankovic K; Zunec R
    Hum Immunol; 2017 Nov; 78(11-12):665-671. PubMed ID: 28887054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.
    Bettens F; Passweg J; Schanz U; Chalandon Y; Heim D; Güngör T; Stussi G; Nicoloso G; Baldomero H; Gratwohl A; Tiercy JM
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):608-16. PubMed ID: 21963878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles.
    Shaw BE; Mayor NP; Russell NH; Apperley JF; Clark RE; Cornish J; Darbyshire P; Ethell ME; Goldman JM; Little AM; Mackinnon S; Marks DI; Pagliuca A; Thomson K; Marsh SG; Madrigal JA
    Leukemia; 2010 Jan; 24(1):58-65. PubMed ID: 19924143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.